JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB318988

Anti-influenza A H1N1 (A/California/07/2009) neuraminidase 抗体 [CD6]

Anti-influenza A H1N1 (A/California/07/2009) neuraminidase antibody [CD6]

Be the first to review this product! Submit a review

|

(0 Publication)

Mouse Recombinant Monoclonal N1, influenza H1N1, A/California/07/2009 antibody. Suitable for ICC/IF, I-ELISA and reacts with Transfected cell line - Influenza A virus (A/California/07/2009(H1N1)), Recombinant full length protein - Influenza A virus (A/California/07/2009(H1N1)) samples.

別名を表示する

C3W6G3, C3W6G3_9INFA, Neuraminidase, N1, influenza H1N1, A/California/07/2009

2 Images
Immunocytochemistry/ Immunofluorescence - Anti-influenza A H1N1 (A/California/07/2009) neuraminidase antibody [CD6] (AB318988)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-influenza A H1N1 (A/California/07/2009) neuraminidase antibody [CD6] (AB318988)

Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 0.1% TritonX-100 permeabilized 293T (human embryonic kidney epithelial cell) cells labelling influenza A H1N1 (A/California/07/2009) neuraminidase with ab318988 at 1/2000 (0.465 ug/ml) dilution, followed by ab150113 Goat Anti-Mouse IgG H&L (Alexa Fluor® 488) antibody at 1/1000 (2ug/ml) dilution (Green).

Confocal image showing cytoplasmic and membranous staining in 293T cells transfected with a N1, H1N1, A/California/07/2009 expression vector containing a myc-His-tag® (shown in green) but no staining in 293T cells transfected with a N9, H7N9, A/Anhui/1/2013 or N1, H1N1, A/Brisbane/59/2007 vector containing a myc-His-tag®. The counterstain was observed in magenta. Nuclear DNA was labeled with DAPI (shown in blue).
A : Myc transfected cells
B : N1, H1N1, A/Brisbane/59/2007-Myc transfected cells
C : N1, H1N1, A/California/07/2009-Myc transfected cells
D : N9, H7N9, A/Anhui/1/2013-Myc transfected cells
Image was taken with a confocal microscope(Leica-Microsystems, TCS SP8).

ab9106 Anti-Myc Rabbit polyclonal antibody was used to counterstain tubulin at 1/200 (2.5 ug/ml) dilution (Magenta). The nuclear counterstain was DAPI (Blue).

Secondary antibody only control : Secondary antibody is ab150113 Goat Anti-Mouse IgG H&L (Alexa Fluor® 488) at 1/1000 (2ug/ml) dilution.

Indirect ELISA - Anti-influenza A H1N1 (A/California/07/2009) neuraminidase antibody [CD6] (AB318988)
  • I-ELISA

Supplier Data

Indirect ELISA - Anti-influenza A H1N1 (A/California/07/2009) neuraminidase antibody [CD6] (AB318988)

Indirect ELISA analysis of ab318988 at 2000 ng/ml. The secondary antibody used was Alkaline Phosphatase-conjugated AffiniPure Goat Anti-Mouse IgG (H+L) at 1 : 1000 dilution. Antigen : N1, influenza H1N1, A/California/07/2009. Antigen concentration : 0-1000 ug/ml.

関連する標識済み抗体及び組成の異なる製品 (1)

  • Carrier free

    Anti-influenza A H1N1 (A/California/07/2009) neuraminidase antibody [CD6] - BSA and Azide free

Key facts

宿主種

Mouse

クローン性

Monoclonal

クローン番号

CD6

アイソタイプ

IgG2a

キャリアフリー

No

交差種

Influenza A virus (A/California/07/2009(H1N1))

アプリケーション

I-ELISA, ICC/IF

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

特異性

<p>This antibody reacts with Influenza A virus H1N1, A/California/07/2009 neuraminidase and does not react with Influenza A virus H1N1, A/Brisbane/59/2007 neuraminidase or Influenza A virus H7N9, A/Anhui/1/2013 neuraminidase.</p>

style
left-column

組合せ製品

Primary Antibodies

AB318986

Anti-influenza A H1N1 (A/Brisbane/59/2007) neuraminidase antibody [3A2]

Recombinant

Immunocytochemistry/ Immunofluorescence - Anti-influenza A H1N1 (A/Brisbane/59/2007) neuraminidase antibody [3A2] (AB318986)

  • 0
  • 0
Primary Antibodies

AB313343

Anti-Influenza A Virus Nucleoprotein antibody [EPR28253-17]

20ul selling size|RabMAb|Recombinant

Immunocytochemistry/ Immunofluorescence - Anti-Influenza A Virus Nucleoprotein antibody [EPR28253-17] (AB313343)

  • 5
  • 1
Primary Antibodies

AB281519

Anti-MASP2 antibody [EPR23588-1] - BSA and Azide free (Capture)

RabMAb|Recombinant

Sandwich ELISA - Anti-MASP2 antibody [EPR23588-1] - BSA and Azide free (Capture) (AB281519)

  • 0
  • 0
Primary Antibodies

AB21304

Anti-Avian Influenza A Neuraminidase antibody

ELISA - Anti-Avian Influenza A Neuraminidase antibody (AB21304)

  • 2
  • 1
style
left-column

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "IELISA" : {"fullname" : "Indirect ELISA", "shortname":"I-ELISA"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Influenza A virus (A/California/07/2009(H1N1))": { "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "IELISA-species-checked": "predicted", "IELISA-species-dilution-info": "", "IELISA-species-notes": "", "WB-species-checked": "notRecommended", "WB-species-dilution-info": "", "WB-species-notes": "<p></p>" }, "Recombinant full length protein - Influenza A virus (A/California/07/2009(H1N1))": { "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "IELISA-species-checked": "testedAndGuaranteed", "IELISA-species-dilution-info": "2000 ng/mL", "IELISA-species-notes": "<p></p>", "WB-species-checked": "notRecommended", "WB-species-dilution-info": "", "WB-species-notes": "" }, "Transfected cell line - Influenza A virus (A/California/07/2009(H1N1))": { "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/2000", "ICCIF-species-notes": "<p></p>", "IELISA-species-checked": "notRecommended", "IELISA-species-dilution-info": "", "IELISA-species-notes": "", "WB-species-checked": "notRecommended", "WB-species-dilution-info": "", "WB-species-notes": "" } } }
style
left-column

製品の詳細

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Want a custom formulation?
This antibody clone is manufactured by Abcam. If you require a custom buffer formulation or conjugation for your experiments, please contact orders@abcam.com

style
left-column

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Affinity purification Protein A
バッファー組成
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
出荷温度
Blue Ice
短期保存期間
1-2 weeks
短期保存温度
+4°C
長期保存温度
-20°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Avoid freeze / thaw cycle
style
left-column

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

Influenza A H1N1 (A/California/07/2009) neuraminidase also known as NA is an enzyme important for the viral life cycle. It cleaves sialic acid groups from glycoproteins facilitating the release of new virus particles from host cells. This process aids the spread of infection within the host. Neuraminidase of H1N1 has a molecular mass of around 60 kDa. It is expressed on the surface of the influenza virus where it functions to support the viral budding process.
Biological function summary

Neuraminidase enables the influenza virus to exit infected cells and invade new ones ensuring efficient viral dissemination. It functions as part of a complex with the viral hemagglutinin protein which helps the virus attach to the host cell surface before infection. Neuraminidase's enzymatic action counteracts hemagglutinin's binding by cutting sialic acid residues from host receptors an essential function for viral replication.

Pathways

Neuraminidase plays a role in the influenza viral budding and release pathway coordinating with hemagglutinin to manage the balance between virus attachment and release. This action relates to various antiviral research efforts aimed at blocking this process focusing on the hemagglutinin-neuraminidase balance. Interventions at this level may inhibit the virus' ability to proliferate highlighting the importance of neuraminidase in therapeutic pathways targeting influenza.

Neuraminidase is directly linked to influenza infection a respiratory illness with pandemic potential. Inhibitors like oseltamivir and zanamivir are designed to block neuraminidase activity preventing the virus' spread in the body. These inhibitors target the interaction between neuraminidase and sialic acid residues aiming to disrupt the pathogenesis of the influenza virus. This interaction offers a promising target for therapeutic strategies against influenza virus strains including potential drug-resistant variants.
style
left-column
style
left-column

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:
style
left-column

ターゲットの情報

See full target information N1, influenza H1N1, A/California/07/2009
style
left-column
style
left-column
style
right-column

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com